Division of Hematology
The Cardeza Foundation for Hematologic Research was founded in 1939 by Mr. and Mrs. Thomas D. Cardeza as a memorial to Mr. Cardeza’s mother, Charlotte Drake Cardeza. Since that time the Foundation has supported Hematologic research and the Division of Hematology in the Department of Medicine at the Jefferson Medical College of the Thomas Jefferson University. Such support has fulfilled the gracious intentions of the Cardezas and enabled creation of one of the premier academic Hematology programs in the world.
The Cardeza Foundation for Hematologic Research has a proud, beginning with its first Director, Dr. Harold Jones, who was a respected Hematologist and personal physician to Mrs. Cardeza. The second Director, Dr. Alan Erslev, was an internationally acclaimed Hematologist who discovered erythropoietin and trai ned numerous academic Hematologists. The third Director, Dr. Sandy Shapiro, was an outstanding clinician-scientist who made seminal contributions in coagulation and founded the Cardeza Hemophilia Center. Dr. Steven McKenzie, the fourth director; continues to perform cutting-edge research on heparin-induced thrombocytopenia, to direct the Cardeza Hemophilia Center and is Vice President of Research at Thomas Jefferson University.
THE CARDEZA FOUNDATION for
cordially invites you to its
75th Anniversary Celebration
Friday, September 19, 2014
Scientific Symposia with
Guillermo Garcia-Manero, MD
Barbara Konkle, MD
Perumal Thiagarajan, MD
Leonard Zon, MD
Saturday, September 20, 2014
Contact Pamela Scruci-Cole
Currently, the Cardeza Foundation supports faculty salaries, research programs, education programs and administration located on the 3rd floor of Jefferson Alumni Hall
In the News
Paul Bray, M.D. received NIH grant to study the role of miRNA in Megakaryocytes.
Paul Bray interviewed by Nature Medicine Podcast
Michael Holinstat, Ph.D. received the 2013 Young Investigator Award on Structure-Function from the Eicosanoid Research Foundation at the 13th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases.
Michael Holinstat, Ph.D. receives Three Grant Awards from the NIGMS to study 12-HETRE Regulation of Platelets, from the NHLBI to study the Role of 12-Lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus, and from the NIMHD to study the Genetic Regulation of Racial Differences in Platelet Reactivity.
for Platelet Study
Jefferson is studying blood clot formation. Seeking healthy 18 yr. old +, M/,F non-smoking, participants to donate blood. Volunteers will be compensated and can donate up to 2x per week.
Call M. Holinstat, PhD (215) 955-8544